UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 24, 2022
Accession Number: 0001213900-22-031186
Submission Type: POS AM
CIK: 0001690080
Company Name: 180 Life Sciences Corp.
File Number: 333-259209